
Taxol extravasation: A case report
Author(s) -
Wendy L. Bailey,
R. Michael Crump
Publication year - 1997
Publication title -
canadian oncology nursing journal
Language(s) - Uncategorized
Resource type - Journals
eISSN - 2368-8076
pISSN - 1181-912X
DOI - 10.5737/1181912x729697
Subject(s) - extravasation , intervention (counseling) , medicine , drug , pharmacology , intensive care medicine , pathology , psychiatry
Taxol is a relatively new antineoplastic agent whose classification as either vesicant, non-vesicant, or irritant remains under debate. This case study is presented to follow a large-volume Taxol extravasation. The article illustrates assessment, follow-up, intervention and outcome of this situation. This case suggests the drug is a vesicant with the potential to cause moderate soft tissue injury.